Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-15 Birchler Brian EVP, Corp and Development Ops Grant or award · Restricted Stock Unit +20,400 58,328
2024-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Performance Restricted Stock Units +17,000 41,482
2024-01-15 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Restricted Stock Unit +20,400 41,814
2024-01-15 Baroldi Joseph EVP, Chief Business Officer Grant or award · Performance Restricted Stock Units +17,000 29,290
2024-01-15 Baroldi Joseph EVP, Chief Business Officer Grant or award · Restricted Stock Unit +20,400 67,661
2024-01-15 Baroldi Joseph EVP, Chief Business Officer Grant or award · Restricted Stock Unit +1,800 5,762
2024-01-15 Baroldi Joseph EVP, Chief Business Officer Grant or award · Restricted Stock Unit +2,625 8,387
2024-01-12 Schneider Eugene EVP, Chf Clinical Develop Ofcr Exercise or conversion 10b5-1 +8,000 $32.60 $261K 46,170
2024-01-12 Schneider Eugene EVP, Chf Clinical Develop Ofcr Sale 10b5-1 −8,000 $53.50 $428K 38,170
2024-01-12 Schneider Eugene EVP, Chf Clinical Develop Ofcr Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 −8,000 24,265
2024-01-02 Swayze Eric EVP Research Grant or award · Non-Qualified Stock Option (right to buy) +27,200 27,200
2024-01-02 Swayze Eric EVP Research Grant or award · Non-Qualified Stock Option (right to buy) +154 154
2024-01-02 Schneider Eugene EVP, Chf Clinical Develop Ofcr Grant or award · Non-Qualified Stock Option (right to buy) +27,200 27,200

Page 44 of 44 · 873 trades